HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 196 filers reported holding HERON THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.26 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $7,674,000 | +53.4% | 326,574 | +20.8% | 1.26% | +48.2% |
Q3 2019 | $5,002,000 | +3.3% | 270,389 | +3.8% | 0.85% | +13.1% |
Q2 2019 | $4,843,000 | -26.5% | 260,490 | -3.3% | 0.75% | -26.7% |
Q1 2019 | $6,587,000 | +0.1% | 269,514 | +6.3% | 1.02% | -21.7% |
Q4 2018 | $6,578,000 | -20.7% | 253,600 | -3.2% | 1.30% | +24.8% |
Q3 2018 | $8,291,000 | – | 261,970 | – | 1.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |